Who other than the SHs can penetrate the curtains of commercial in confidence?
Who are responsible to scrutinise if there are anomalies made by the management and if their misleading words misguided the market?
Where are third party inquirirs of the delay whether it caused by the BIT management or the CROs management?
Who will take care of the SHs' right to access to the information of what the CEO and CROs are doing under the curtains of the commercial in confidence?
SPs is below 2c for prolonged period of time.
Do the SHs need a CEO like mm whose updates diminish SHs' confidence?
Do the SHs want to feed the CEO who has been taking money just for making excuses after excuses and fluff and bluff after fluff and bluff?
Where is the roadmap and deadline for the growth path?
If no growth path, then why are the management taking salaries?
Who can intervene to dismantle their planned way of taking and making money for a prolonged period of time without giving anyhting tangible whatsoever?
How helpless the SHs are! The regulators should petrol over the CEO and grill the CEO to avoid misusing the commercial in confidence and give a moratorium on their salary until tangible outcome- either stay unpaid or leave unpaid and pay the fines for misleading and apprpriating the SHs' and tax payers' money. If there are no scrtinies on the actions of the people like Peter Gage and Michelle Miller, there will be many more to cheat the systems and the SHs with their sh!te
AGM and options are all bogus until MM announces that Gilead is going to ACQUIRE Biotron at $0.6/s subject to SHs' approval.
- Forums
- ASX - By Stock
- BIT in 2018 to 2024 - Hopes and Hypes - CEO's misleading - what's Next?
BIT
biotron limited
Add to My Watchlist
0.00%
!
0.2¢

Who other than the SHs can penetrate the curtains of commercial...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.654M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $210 | 104.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 38848316 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 18281126 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
59 | 37148316 | 0.002 |
33 | 65631001 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 14162401 | 23 |
0.004 | 12820969 | 17 |
0.005 | 6684000 | 5 |
0.006 | 1200000 | 2 |
0.007 | 1084188 | 2 |
Last trade - 12.28pm 27/06/2025 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online